U.S. President Donald Trump announced on Friday that the federal government is taking steps to expand access to GLP-1 ...

A recent study suggests that GLP-1 drugs could reduce asthma exacerbations in patients with overweight or obesity.

As many of us know, keeping weight in check can be hard. National numbers certainly reflect this. Rates of overweight and ...

Specialty drugs are an increasing worry for health plans and employers as new and innovative therapies enter the U.S. market ...

A mind-bending hallucinogen is moving out of the counterculture and into the clinic. The Food and Drug Administration on ...

New research has shown that GLP‑1 weight-loss drugs deliver protection against heart attacks, strokes, and premature death over a sustained period of time. Researchers from Anglia Ruskin University ...

Psilocybin, which is from magic mushrooms, is being studied for treatment-resistant depression and major depressive disorder.

DTC portals for drugs are a solution to a problem that wouldn’t exist if insurer coverage were better. The most acute issue ...